Insilico Medicine
About Insilico Medicine
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and to design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases and aging-related diseases. Headquartered in Hong Kong, Insilico Medicine has additional offices in New York, Montreal, Shanghai, Suzhou, Taipei, and Abu Dhabi.
Shared 1 month ago
117 views
Shared 1 month ago
225 views
Shared 2 months ago
260 views
Shared 4 months ago
334 views
Shared 4 months ago
721 views
Shared 4 months ago
1.1K views
Shared 5 months ago
420 views
Shared 5 months ago
1.3K views
Shared 7 months ago
971 views
Shared 8 months ago
401 views
Shared 8 months ago
296 views
Shared 10 months ago
1.7K views
Shared 11 months ago
6.9K views
Shared 1 year ago
2.1K views
Shared 1 year ago
724 views
Shared 1 year ago
677 views
Shared 1 year ago
820 views
Shared 1 year ago
1.7K views
Shared 1 year ago
1.4K views
Shared 1 year ago
1K views
Shared 1 year ago
955 views
Shared 2 years ago
2.6K views
Shared 2 years ago
1.2K views
Shared 2 years ago
2.4K views
Shared 2 years ago
4.7K views
Shared 2 years ago
2.3K views
PandaOmics 3.0 - the tool for OMICS Data Analysis, Pathway Analysis and Visualization, and Target ID
Shared 2 years ago
7.2K views
Shared 2 years ago
1.3K views
Shared 2 years ago
333 views
Shared 2 years ago
1.1K views
Shared 3 years ago
29K views
Shared 3 years ago
2.6K views
Shared 3 years ago
2.9K views
Shared 3 years ago
1.3K views
